Summary:
Australian startup Cauldron Ferm has developed a solution for a major challenge in synthetic biology by transforming microbes into continuous assembly lines for its customers.
Bullet points:
– Cauldron Ferm has successfully enabled microbes to operate as nonstop assembly lines in synthetic biology.
– The startup’s innovation addresses a key hurdle for companies in the synthetic biology sector.
– The technology breakthrough offers promising prospects for improved efficiency and productivity in biological manufacturing.